Industries > Pharma > Biobanking Market Forecasts 2018-2028

Biobanking Market Forecasts 2018-2028

Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key Geographies

PUBLISHED: 24 May 2018
PAGES: 266
PRODUCT CODE: PHA0310

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

Biobanking – our new study reveals trends, R&D progress, and predicted revenues
Where is the Biobanking market heading? If you are involved in this sector you must read this brand-new report. Visiongain’s report shows you the potential revenues streams to 2028, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 266-page report provides 145 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted drug sales at overall world market regional level, as well as giving a deep insight into the pipeline for Biobanking. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking market. See how to exploit these opportunities.

Forecasts to 2028 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2028, our new study provides you with recent results, R&D overview, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and following Biobanking Submarkets:

• Biobanking for Research:
• Human Tissue:
– Commercial
– Public
• Stem Cells
• Others (DNA, Blood fluids etc.)

• Biobanking for Therapeutic Use:
• Umbilical Cord Banking
• Adult Stem Cell Banking

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets:
• US
• Germany
• France
• The UK
• Spain
• Italy
• The Netherlands
• Japan
• China
• India
• Brazil
• Russia
• RoW

Biobanking Market Forecasts 2018-2028

Our analysis shows activities of biobanks, including these organisations:
• Stemgent
• Biopta
• BioServe
• Coriell Institute for Medical Research
• Cord Blood America
• Cryo-Cell International.

And other companies, including these:
• China Cord Blood Corp
• LifebankUSA
• ViaCord
• Cord Blood Registry
• Biogenea Pharmaceuticals
• StemLife
• Caladrius Biosciences.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2028.

Leading companies and the potential for market growth
Overall world revenue for Biobanking will surpass $35bn in 2023, our work calculates. This will be driven by the use of biobanking in drug development and medical research, as well as the expected rise in number of commercial biobanks over the forecast period

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Biobanking Market report helps you
In summary, our 266-page report provides you with the following knowledge:
• Revenue forecasts to 2028 for the Biobanking market and Leading Submarkets – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2028 for 12 of the leading national markets – US, Germany, France, UK, Italy, Spain, Netherlands, Japan, Russia, China, India, Brazil
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
– including company profiles for 16 companies involved in commercial biobanking and biobanking for therapeutic use

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the Biobanking market and leading companies. You will find data, trends and predictions.

Get our report today Biobanking Market Forecasts 2018-2028: Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key Geographies. Avoid missing out – get our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Biobanking Market Forecasts 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Biobanking Market Forecasts 2018-2028


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category